<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">inovmed</journal-id><journal-title-group><journal-title xml:lang="ru">Инновационная медицина Кубани</journal-title><trans-title-group xml:lang="en"><trans-title>Innovative Medicine of Kuban</trans-title></trans-title-group></journal-title-group><issn pub-type="epub">2541-9897</issn><publisher><publisher-name>Scientific Research Institute – Ochapovsky Regional Clinical Hospital No. 1</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.35401/2500-0268-2020-20-4-20-26</article-id><article-id custom-type="elpub" pub-id-type="custom">inovmed-329</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLES</subject></subj-group></article-categories><title-group><article-title>Маркеры окислительного стресса у пациентов с синдромом зависимости от опиоидов и психостимуляторов</article-title><trans-title-group xml:lang="en"><trans-title>Oxidative stress markers in patients suffering from opioid and psychostimulant dependence syndrome</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1787-0040</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Быков</surname><given-names>И. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Bykov</surname><given-names>I. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Быков Илья Михайлович, д. м. н., заведующий кафедрой фундаментальной и клинической биохимии</p><p>350063, Краснодар, ул. М. Седина, 4 </p></bio><bio xml:lang="en"><p>Iliya M. Bykov, Dr. of Sci. (Med.), Professor, Head of the Department of Basic and Clinical Biochemistry </p><p>Krasnodar</p></bio><email xlink:type="simple">ilya.bh@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9207-4546</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Любченко</surname><given-names>Д. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Lubchenko</surname><given-names>D. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Любченко Дмитрий Александрович, ассистент кафедры фундаментальной клинической биохимии</p><p>Краснодар</p></bio><bio xml:lang="en"><p>Dmitry A. Lubchenko, Assistant Professor, Department of Basic and Clinical Biochemistry</p><p>Krasnodar</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3649-1361</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Попов</surname><given-names>К. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Popov</surname><given-names>K. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Попов Константин Андреевич, к. м. н., доцент кафедры фундаментальной клинической биохимии</p><p>Краснодар</p></bio><bio xml:lang="en"><p>Konstantin A. Popov, Cand. of Sci. (Med.), Associate Professor, Department of Basic and Clinical Biochemistry</p><p>Krasnodar</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1242-6909</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Денисова</surname><given-names>Я. Е.</given-names></name><name name-style="western" xml:lang="en"><surname>Denisova</surname><given-names>Ya. Ye.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Денисова Яна Евгеньевна, ассистент кафедры фундаментальной клинической биохимии</p><p>Краснодар</p></bio><bio xml:lang="en"><p>Yana Ye. Denisova, Assistant Professor, Department of Basic and Clinical Biochemistry</p><p>Krasnodar</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5817-130X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Столярова</surname><given-names>А. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Stolyarova</surname><given-names>A. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Столярова Анжела Николаевна, ассистент кафедры фундаментальной клинической биохимии</p><p>Краснодар</p></bio><bio xml:lang="en"><p>Anzhela N. Stolyarova, Assistant Professor, Department of Basic and Clinical Biochemistry</p><p>Krasnodar</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8206-6043</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Попова</surname><given-names>М. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Popova</surname><given-names>M. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Попова Муня Андреевна, врач – психиатр-нарколог</p><p>Краснодар</p></bio><bio xml:lang="en"><p>Munya A. Popova, Addiction Psychiatrist</p><p>Krasnodar</p></bio><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Кубанский государственный медицинский университет</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Kuban State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Наркологический диспансер</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Drug Abuse Clinic under the Krasnodar Krai Ministry of Health</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2020</year></pub-date><pub-date pub-type="epub"><day>30</day><month>12</month><year>2020</year></pub-date><volume>0</volume><issue>4</issue><fpage>20</fpage><lpage>26</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Быков И.М., Любченко Д.А., Попов К.А., Денисова Я.Е., Столярова А.Н., Попова М.А., 2020</copyright-statement><copyright-year>2020</copyright-year><copyright-holder xml:lang="ru">Быков И.М., Любченко Д.А., Попов К.А., Денисова Я.Е., Столярова А.Н., Попова М.А.</copyright-holder><copyright-holder xml:lang="en">Bykov I.M., Lubchenko D.A., Popov K.A., Denisova Y.Y., Stolyarova A.N., Popova M.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.innovmedkub.ru/jour/article/view/329">https://www.innovmedkub.ru/jour/article/view/329</self-uri><abstract><sec><title>Актуальность</title><p>Актуальность. Данные клинических исследований позволяют утверждать о существенной роли свободнорадикальных процессов в патогенезе синдрома наркотической зависимости. При этом вопрос использования маркеров окислительного стресса в лабораторном мониторинге и прогнозировании наркопатологии раскрыт недостаточно.</p></sec><sec><title>Цель</title><p>Цель. Характеристика изменений перспективных маркеров окислительного стресса у пациентов с синдромом зависимости от опиоидов и психостимуляторов.</p></sec><sec><title>Материал и методы</title><p>Материал и методы. Исследование проведено на трех группах испытуемых лиц мужского пола 23–35 лет: относительно здоровые лица (n = 20), пациенты с синдромом зависимости от опиоидов (n = 20) и психостимуляторов (n = 20). Изучена динамика маркеров окислительного стресса в процессе стационарной терапии синдрома зависимости, направленной на коррекцию основных психических нарушений и дезинтоксикацию.</p></sec><sec><title>Результаты</title><p> Результаты. Значения антиоксидантной активности и тиоловых групп плазмы крови не отличались у пациентов с зависимостью от разных наркотических веществ и на протяжении всего исследования были на 20–30% ниже аналогичных показателей участников контрольной группы. Характер изменений показателей эритроцитарной взвеси был не таким однозначным. Для пациентов с синдромом зависимости от опиоидов было характерно увеличенное на 91% содержание ТБК- (тиобарбитуровой кислоты) реактивных продуктов на фоне незначительно измененного состояния показателей системы глутатиона. В эритроцитах пациентов с синдромом зависимости от психостимуляторов был сравнительно невысокий уровень содержания продуктов окислительных модификаций биомолекул – на 52% выше аналогичных значений у пациентов контрольной группы. В процессе терапии он снижался, однако были определены сниженная концентрация глутатиона на 33% и дисбаланс ферментов его метаболизма.</p></sec><sec><title>Заключение</title><p>Заключение. Течение синдрома зависимости от опиоидов характеризуется выраженной интенсификацией свободнорадикальных процессов, тогда как зависимости от психостимуляторов свойственны более значительные изменения системы антиоксидантной защиты. Поэтому в первом случае наиболее оправдано проведение лабораторной оценки маркеров окислительных повреждений, а во втором целесообразно дополнительно определить маркеры состояния отдельных звеньев антиоксидантной системы.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Background</title><p>Background. The available data from clinical studies suggest the essential role of free radical processes in the pathogenesis of drug dependence syndrome. At the same time, there is a limited understanding of using markers of oxidative stress in laboratory monitoring and prediction of drug pathology.</p></sec><sec><title>Objective</title><p>Objective. To characterize changes in promising indicators of oxidative stress in patients with psychostimulant and opioid dependence syndrome.</p></sec><sec><title>Material and Methods</title><p>Material and Methods. The total study population was divided into three groups of men aged 23–35: healthy controls (n = 20), patients with the opioid (n = 20) and psychostimulant (n = 20) dependence syndrome. Patients were analyzed for the oxidative stress markers while being in therapy for addiction syndrome aimed at treating mental disorders and detoxification.</p></sec><sec><title>Results</title><p>Results. The study of antioxidant activity and blood plasma thiol groups did not reveal any significant differences between patients suffering from opioid and psychostimulant addiction. The values of the parameters mentioned above were maintained by 20–30% lower than the control indices throughout the entire study. The nature of changes in erythrocyte suspension parameters was not so unambiguous. Thus, patients with opioid dependence syndrome were characterized by a 91% increase in thiobarbituric acid (TBA)-reactive materials in the setting of a slightly altered state of the glutathione system parameters. Psychostimulant dependent patients revealed relatively low level of the products of biomolecule oxidative modifications in the erythrocytes that is 52% higher compared to the control values. It decreased during the therapy, but glutathione concentration reduction by 33% and an imbalance of glutathione metabolism were determined.</p></sec><sec><title>Conclusion</title><p>Conclusion. The course of the opioid dependence syndrome is characterized by a pronounced intensification of free radical processes while the common trait for psychostimulant abusers is significant changes in the antioxidant defense system. Therefore, in the first case, it is most justified to conduct a laboratory assessment of indicators of oxidative damage, and in the second one, it is also advisable to determine the markers of the state of individual links of the antioxidant system.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>окислительный стресс</kwd><kwd>лабораторные маркеры</kwd><kwd>антиоксидантная система</kwd><kwd>наркотическая зависимость</kwd><kwd>опиоиды</kwd><kwd>психостимуляторы</kwd></kwd-group><kwd-group xml:lang="en"><kwd>oxidative stress</kwd><kwd>laboratory markers</kwd><kwd>antioxidant system</kwd><kwd>drug abuse</kwd><kwd>opioids</kwd><kwd>psychostimulants</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Абрамов А.Ю. Вопросы регулирования оборота и потребления наркотических средств и психотропных веществ. М.: ГЭОТАР-Медиа; 2017. 256 с.</mixed-citation><mixed-citation xml:lang="en">Abramov AYu. Issues of Regulation of the Turnover and Consumption of Narcotic Drugs and Psychotropic Substances. Moscow: GEOTAR-Media; 2017. 256 p. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Коршунов В.А., Миндлина А.Я., Вязовиченко Ю.Е. Анализ системы первичной профилактики наркомании в Российской Федерации и предложения по ее оптимизации. Сеченовский вестник. 2016;1(23):31–8.</mixed-citation><mixed-citation xml:lang="en">Korshunov VA, Mindlina AYa, Vjazovichenko YuE. Analysis of the Russian primary drug abuse prevention system and proposals for its optimization. Sechenov Medical Journal. 2016;1(23):31–8. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Peacock A, Leung J, Larney S, et al. Global statistics on alcohol, tobacco and illicit drug use: 2017 status report. Addiction. 2018;113(10):1905–26. PMID: 29749059. https://doi.org/10.1111/add.14234 26</mixed-citation><mixed-citation xml:lang="en">Peacock A, Leung J, Larney S, et al. Global statistics on alcohol, tobacco and illicit drug use: 2017 status report. Addiction. 2018;113(10):1905–26. PMID: 29749059. https://doi.org/10.1111/add.1423426</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">World Drug Report 2015. Vienna, New York: United Nations Office on Drugs and Crime; 2015. Accessed from: https://www.unodc.org/documents/wdr2015/World_Drug_Report_2015.pdf</mixed-citation><mixed-citation xml:lang="en">World Drug Report 2015. Vienna, New York: United Nations Office on Drugs and Crime; 2015. Accessed from: https://www.unodc.org/documents/wdr2015/World_Drug_Report_2015.pdf</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Martens M-S, Zurhold H, Rosenkranz M, et al. Using life course charts to assess and compare trajectories of amphetamine type stimulant consumption in different user groups: a cross-sectional study. Harm Reduct J. 2020;17(1):8. PMID: 31931819. PMCID: PMC6956476. https://doi.org/10.1186/s12954-019-0339-x</mixed-citation><mixed-citation xml:lang="en">Martens M-S, Zurhold H, Rosenkranz M, et al. Using life course charts to assess and compare trajectories of amphetamine type stimulant consumption in different user groups: a cross-sectional study. Harm Reduct J. 2020;17(1):8. PMID: 31931819. PMCID: PMC6956476. https://doi.org/10.1186/s12954-019-0339-x</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Любченко Д.А., Редько А.Н., Агибалова Т.В. Особенности организации медико-социальной реабилитации потребителей психостимуляторов с учетом их личностных характеристик. Наркология. 2013;12(9):77–84.</mixed-citation><mixed-citation xml:lang="en">Lubchenko DA, Redko AN, Agibalova TV. Features of the organization of medical and social rehabilitation of psychostimulant consumers based on their personal characteristics. Narcology. 2013;12(9):77–84. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Shen W, Liu H, Xie X, Liu H, Zhou W. Biochemical diagnosis in substance and non-substance addiction. Adv Exp Med Biol. 2017;1010:169–202. PMID: 29098673. https://doi.org/10.1007/978-981-10-5562-1_9</mixed-citation><mixed-citation xml:lang="en">Shen W, Liu H, Xie X, Liu H, Zhou W. Biochemical diagnosis in substance and non-substance addiction. Adv Exp Med Biol. 2017;1010:169–202. PMID: 29098673. https://doi.org/10.1007/978-981-10-5562-1_9</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Heberlein A, Käser M, Lichtinghagen R, et al. TNF-α and IL-6 serum levels: neurobiological markers of alcohol consumption in alcohol-dependent patients? Alcohol. 2014;48:671–6. PMID: 25262503. https://doi.org/10.1016/j.alcohol.2014.08.003</mixed-citation><mixed-citation xml:lang="en">Heberlein A, Käser M, Lichtinghagen R, et al. TNF-α and IL-6 serum levels: neurobiological markers of alcohol consumption in alcohol-dependent patients? Alcohol. 2014;48:671–6. PMID: 25262503. https://doi.org/10.1016/j.alcohol.2014.08.003</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Huang M-Ch, Lin Sh-K, Chen Ch-H, Pan Ch-H, Lee Ch-H, Liu H-Ch. Oxidative stress status in recently abstinent methamphetamine abusers. Psychiatry Clin Neurosci. 2013;67:92–100. PMID: 23438161. https://doi.org/10.1111/pcn.12025</mixed-citation><mixed-citation xml:lang="en">Huang M-Ch, Lin Sh-K, Chen Ch-H, Pan Ch-H, Lee Ch-H, Liu H-Ch. Oxidative stress status in recently abstinent methamphetamine abusers. Psychiatry Clin Neurosci. 2013;67:92–100. PMID: 23438161. https://doi.org/10.1111/pcn.12025</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Luan X, Chen H, Qiu H, et al. Association between serum malondialdehyde levels and depression during early methamphetamine withdrawal. Neurosci Lett. 2018;687:22–5. PMID: 30219487. https://doi.org/10.1016/j.neulet.2018.09.021</mixed-citation><mixed-citation xml:lang="en">Luan X, Chen H, Qiu H, et al. Association between serum malondialdehyde levels and depression during early methamphetamine withdrawal. Neurosci Lett. 2018;687:22–5. PMID: 30219487. https://doi.org/10.1016/j.neulet.2018.09.021</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Azmy ShM, Abd El Fattah MA, Abd El-Rahman SS, et al. Does nicotine impact tramadol abuse? Insights from neurochemical and neurobehavioral changes in mice. Neurotoxicology. 2018;67:245–58. PMID: 29906478. https://doi.org/10.1016/j.neuro.2018.06.004</mixed-citation><mixed-citation xml:lang="en">Azmy ShM, Abd El Fattah MA, Abd El-Rahman SS, et al. Does nicotine impact tramadol abuse? Insights from neurochemical and neurobehavioral changes in mice. Neurotoxicology. 2018;67:245–58. PMID: 29906478. https://doi.org/10.1016/j.neuro.2018.06.004</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Bameri B, Shaki F, Ahangar N, Ataee R, Samadi M, Mohammadi H. Evidence for the involvement of the dopaminergic system in seizure and oxidative damage induced by tramadol. Int J Toxicol. 2018;37:164–70. PMID: 29554822. https://doi.org/10.1177/1091581817753607</mixed-citation><mixed-citation xml:lang="en">Bameri B, Shaki F, Ahangar N, Ataee R, Samadi M, Mohammadi H. Evidence for the involvement of the dopaminergic system in seizure and oxidative damage induced by tramadol. Int J Toxicol. 2018;37:164–70. PMID: 29554822. https://doi.org/10.1177/1091581817753607</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Mohamed TM, Ghaffar HM, El Husseiny RM. Effects of tramadol, clonazepam, and their combination on brain mitochondrial complexes. Toxicol Ind Health. 2015;31:1325–33. PMID: 23843224. https://doi.org/10.1177/0748233713491814</mixed-citation><mixed-citation xml:lang="en">Mohamed TM, Ghaffar HM, El Husseiny RM. Effects of tramadol, clonazepam, and their combination on brain mitochondrial complexes. Toxicol Ind Health. 2015;31:1325–33. PMID: 23843224. https://doi.org/10.1177/0748233713491814</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Mohamed HM, Mahmoud AM. Chronic exposure to the opioid tramadol induces oxidative damage, inflammation and apoptosis, and alters cerebral monoamine neurotransmitters in rats. Biomed Pharmacother. 2019;110:239–47. PMID: 30508735. https://doi.org/10.1016/j.biopha.2018.11.141</mixed-citation><mixed-citation xml:lang="en">Mohamed HM, Mahmoud AM. Chronic exposure to the opioid tramadol induces oxidative damage, inflammation and apoptosis, and alters cerebral monoamine neurotransmitters in rats. Biomed Pharmacother. 2019;110:239–47. PMID: 30508735. https://doi.org/10.1016/j.biopha.2018.11.141</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Hodes A, Lifschytz T, Rosen H, Cohen Ben-Ami H, Lichtstein D. Reduction in endogenous cardiac steroids protects the brain from oxidative stress in a mouse model of mania induced by amphetamine. Brain Res Bull. 2018;137:356–62. PMID: 29374602. https://doi.org/10.1016/j.brainresbull.2018.01.016</mixed-citation><mixed-citation xml:lang="en">Hodes A, Lifschytz T, Rosen H, Cohen Ben-Ami H, Lichtstein D. Reduction in endogenous cardiac steroids protects the brain from oxidative stress in a mouse model of mania induced by amphetamine. Brain Res Bull. 2018;137:356–62. PMID: 29374602. https://doi.org/10.1016/j.brainresbull.2018.01.016</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Быков И.М., Попов К.А., Егорова И.А., Сторожук А.П. Оценка показателей тиолового метаболизма плазмы крови больных воспалительными заболеваниями органов малого таза при проведении антиоксидантной коррекции. Медицинский вестник Северного Кавказа. 2018;13(2):402–6. https://doi.org/10.14300/mnnc.2018.13062</mixed-citation><mixed-citation xml:lang="en">Bykov IМ, Popov KА, Egorova IА, Storozhuk AP. Assessment of indicators of the thiol metabolism of blood plasma of patients with inflammatory diseases of the small pelvis organs at antioxidant correction. Medical News of the North Caucasus. 2018;13(2):402–6. (In Russ.). https://doi.org/10.14300/mnnc.2018.13062</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Карпищенко А.И. Медицинские лабораторные технологии. Справочник. Т. 2. СПб.: Интермедика; 2002. 600 с.</mixed-citation><mixed-citation xml:lang="en">Karpishchenko AI. Medical Laboratory Technologies. Handbook. Vol. 2. St. Petersburg: Intermedika; 2002. 600 p. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
